Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NATURE INDEX

Uneven attention hampers the drive to control infectious diseases

Despite notable success stories, many conditions still present a complex challenge.
By
  1. Sarah DeWeerdt

    1. Sarah DeWeerdt is a science writer based in Seattle, Washington.

The past century has seen enormous advances in the global fight against infectious disease. There’s the discovery of antibiotics and their development into a suite of treatments; advances in vaccine technology and the eradication of smallpox; and antiviral medications that have transformed HIV from a death sentence into a manageable chronic infection, for example.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 598, S10-S13 (2021)

doi: https://doi.org/10.1038/d41586-021-02910-y

This article is part of Nature Index 2021 Infectious disease, an editorially independent supplement. Advertisers have no influence over the content.

References

  1. Head, M. G. et al. Lancet Glob. Health 8, e1295–e1304 (2020).

    Article  PubMed  Google Scholar 

  2. Graef, F. A. et al. PLoS Pathog. 17, e1009719 (2021).

    Article  PubMed  Google Scholar 

  3. Revill, P. A. et al. Lancet Gastroenterol. Hepatol. 4, 545–558 (2019).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links